Yuqin W. Song - Publications

Research on a dynamic evolution model of driving fatigue-induced musculoskeletal disorders risk

Journal: Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases

Published: September 07, 2026

Current Treatment Landscape and Advances in Lymphoma in China: A Special Issue.

Journal: American journal of hematology

Published: July 30, 2026

Erratum: Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 14, 2026

Diagnosis-to-Treatment Interval Reflects Clinical Urgency and Disease Burden in T-Lymphoblastic Lymphoma: A Multicenter Cohort Study.

Journal: Journal of clinical medicine

Published: July 11, 2026

Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 01, 2026

Webervirus phages exploit capsule- and O-antigen-targeting receptor-binding proteins to access diverse Klebsiella pneumoniae hosts.

Journal: mBio

Published: June 22, 2026

Updates of CSCO guidelines for diagnosis and treatment of lymphoma: 2026 edition.

Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu

Published: June 01, 2026

Validation of the ACGIH hand activity level (HAL) model among automotive manufacturing workers in China

Journal: Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases

Published: May 25, 2026

Comparative analysis of prognostic performance among different lymph node staging systems in gastric cancer

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: May 18, 2026

Phase 1 Trial with Soquelitinib, a Selective ITK Inhibitor for Treatment of Relapsed/Refractory T Cell Lymphomas.

Journal: Blood

Published: April 30, 2026

Multi-omics analysis identifies GAA as an independent poor prognostic biomarker and candidate therapeutic target in angioimmunoblastic T-cell lymphoma.

Journal: Frontiers in immunology

Published: April 22, 2026

Clinical Outcomes of Treatment-Naive Transformed vs. De Novo Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Analysis of 1735 Cases.

Journal: Cancers

Published: April 17, 2026